Recent Federal Actions Put US, Massachusetts Biotech Leadership at Risk: MassBio

By /

MassBio’s new report outlines several concerns, including NIH cuts undermining the research engine, FDA reductions delaying innovation and trade barriers disrupting supply chains.

Scroll to Top